fda714bec0f2cdfbe641df60635bc1a3:5188f746144958e417284685ab2bb34cfdf75d00e7e7ad138a348fef600f269696d1486ecc80f0e0ef7e24f1a0cedd3913a41e5222ad12ede57ffbc638391ac185b28bdf156444bfec2171b5028044d92f35918240619d6df1eed87ed72e9e2842523589b7eff1cafbfaf3890f7fecbba8621d826a3e9f19a68d008648a99ea02e5b0833a7e955116deaaa19de53ec584873c2aeb87b88b2576ac06a2f3fe35d0c556803901a67b0243d387f6065056bd5d0cda998ebf09b92b5695f859e2013e58610b9f61383ac2dce22935bf85fb61fc258759e4ce9b0e9acb9e3264cf9c835e71d3511207720c48d6c731a18ff604d6e7b1998906f680b88d04b3fecb50f0b2b05193ed6de400a1a9cf341ca0ee60eb5fb85640b22bae09cd4abddd0e52585c0fa47aa5038a03fe09f9f1a60b3fbf3d0acd1e9a95a9aa027369be17f3ca987822be3e482b7c49b070ab5615d36ac710d2e6a85c38c2d77d46a5fefef5742df765d864de494bdea6c364dd353b7fd61190b6c81028cd427bb82a93f361ea3448da3e34bbe11ab4ee3249d8ec365b7bf3185d75d5317e1bdbe0be6777e0a2f5f88cd0876085f